Position in AXSM
as of Mar 31, 2026
· filed Apr 22, 2026
Position Value
$3,142,757
-$156,269 QoQ
Shares Held
18,594
+2.9% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
1.23%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in AXSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 20261492 Capital Management LLC holds $15,660,741 across 10 Biotechnology names. AXSM ranks #2 (20.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KURA |
Kura Oncology, Inc.
|
486,123 | $3,952,179 | |
| 2 | AXSM |
Axsome Therapeutics, Inc.
This page
|
18,594 | $3,142,757 | |
| 3 | ARQT |
Arcutis Biotherapeutics, Inc.
|
118,156 | $2,783,755 | |
| 4 | MNKD |
Mannkind Corp
|
549,782 | $1,346,965 | |
| 5 | VKTX |
Viking Therapeutics, Inc.
|
41,181 | $1,340,029 | |
| 6 | DNLI |
Denali Therapeutics Inc.
|
67,417 | $1,294,406 | |
| 7 | ADMA |
Adma Biologics, Inc.
|
113,155 | $1,019,526 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
1,958 | $390,914 |
All Filings in AXSM
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,142,757 | 18,594 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $3,299,026 | 18,063 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $2,193,751 | 18,063 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,236,290 | 11,843 | Shares | Sole | 2025-08-13 | |
| 2024-12-31 | $963,284 | 11,385 | Shares | Sole | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||